Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 302, Issue 6, 2012, Pages

  Datar, Sanjeev A ^a   Johnson, Eric G ^c   Oishi, Peter E ^a,b   Johengen, Michael ^a   Tang, Eric ^a   Aramburo, Angela ^a   Barton, Jubilee ^a   Kuo, Hsuan Chang ^a   Bennett, Stephen ^a   Xoinis, Konstantine ^a   Reel, Bhupinder ^a   Kalkan, Gokhan ^a   Sajti, Eniko ^a   Osorio, Oscar ^a   Raff, Gary W ^c   Matthay, Michael A ^b   Fineman, Jeffrey R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lymph flow; Lymphatic endothelial dysfunction; Lymphatic imaging

Indexed keywords

ANGIOPOIETIN 2; CELL RECEPTOR; LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; NITRIC OXIDE; PLASMA PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; LAMB; LUNG BLOOD FLOW; LYMPH FLOW; MEDIASTINUM LYMPH NODE; NONHUMAN; PLEURA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASODILATATION;

ANGIOPOIETIN-2; ANIMALS; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; LUNG; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; NITRIC OXIDE; PULMONARY ARTERY; PULMONARY CIRCULATION; REGIONAL BLOOD FLOW; SHEEP; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84858175765     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00324.2011     Document Type: Article

References (68)

1. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 438: 946-953, 2005.
2. Allanson JE. Noonan syndrome. J Med Genet 24: 9-13, 1987.
3. Bellini C, Boccardo F, Campisi C, Bonioli E. Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis 1: 43, 2006.
4. Berthiaume Y, Staub NC, Matthay MA. Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 79: 335-343, 1987.
5. Black S, Fineman J, Johengen M, Bristow J, Soifer S. Increased pulmonary blood flow alters the molecular regulation of vascular reactivity in the lamb. Chest 114: 39S, 1998.
6. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97-106, 2000.
7. Black SM, Bekker JM, McMullan DM, Parry AJ, Ovadia B, Reinhartz O, Lakshminrushimha S, Mata-Greenwood E, Steinhorn RH, Fineman JR. Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow. Pediatr Res 52: 233-244, 2002.
8. Black SM, Fineman JR, Steinhorn RH, Bristow J, Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
9. Black SM, Heidersbach RS, McMullan DM, Bekker JM, Johengen MJ, Fineman JR. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol Heart Circ Physiol 277: H1849-H1856, 1999.
10. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res 92: 801-808, 2003.
11. Bohlen HG, Wang W, Gashev A, Gasheva O, Zawieja D. Phasic contractions of rat mesenteric lymphatics increase basal and phasic nitric oxide generation in vivo. Am J Physiol Heart Circ Physiol 297: H1319-H1328, 2009.
12. Coates G, O'Brodovich H, Jefferies AL, Gray GW. Effects of exercise on lung lymph flow in sheep and goats during normoxia and hypoxia. J Clin Invest 74: 133-141, 1984.
13. Collee GG, Lynch KE, Hill RD, Zapol WM. Bedside measurement of pulmonary capillary pressure in patients with acute respiratory failure. Anesthesiology 66: 614-620, 1987.
14. Corbett CR, Dale RF, Coltart DJ, Kinmonth JB. Congenital heart disease in patients with primary lymphedemas. Lymphology 15: 85-90, 1982.
15. Davenport ML. Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 95: 1487-1495, 2010.
16. Dellinger M, Hunter R, Bernas M, Gale N, Yancopoulos G, Erickson R, Witte M. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319: 309-320, 2008.
17. Drake R, Giesler M, Laine G, Gabel J, Hansen T. Effect of outflow pressure on lung lymph flow in unanesthetized sheep. J Appl Physiol 58: 70-76, 1985.
18. Dutka DP, Cousins C, Manhire AR. Lymphatic abnormalities in Alagille's syndrome. Br Heart J 65: 168-170, 1991.
19. Feltes TF, Hansen TN. Effects of an aorticopulmonary shunt on lung fluid balance in the young lamb. Pediatr Res 26: 94-97, 1989.
20. Ferrell RE. Research perspectives in inherited lymphatic disease. Ann NY Acad Sci 979: 39-51; discussion 76-39, 2002.
21. Fineman JR, Wong J, Mikhailov T, Vanderford PA, Jerome HE, Soifer SJ. Altered endothelial function in lambs with pulmonary hypertension and acute lung injury. Pediatr Pulmonol 27: 147-156, 1999.
22. Francois M, Harvey NL, Hogan BM. The transcriptional control of lymphatic vascular development. Physiology 26: 146-155, 2011.
23. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3: 411-423, 2002.
24. Gashev AA, Davis MJ, Zawieja DC. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol 540: 1023-1037, 2002.
25. Gasheva OY, Zawieja DC, Gashev AA. Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct. J Physiol 575: 821-832, 2006.
26. Gibbon JH Jr, Gibbon MH. Experimental pulmonary edema following lobectomy and plasma infusion. Surgery 12: 694-704, 1942.
27. Goldman J, Conley KA, Raehl A, Bondy DM, Pytowski B, Swartz MA, Rutkowski JM, Jaroch DB, Ongstad EL. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol 292: H2176-H2183, 2007.
28. Goldman J, Rutkowski JM, Shields JD, Pasquier MC, Cui Y, Schmokel HG, Willey S, Hicklin DJ, Pytowski B, Swartz MA. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J 21: 1003-1012, 2007.
29. Graziano JN, Heidelberger KP, Ensing GJ, Gomez CA, Ludomirsky A. The influence of a restrictive atrial septal defect on pulmonary vascular morphology in patients with hypoplastic left heart syndrome. Pediatr Cardiol 23: 146-151, 2002.
30. Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fineman JR, Black SM. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol 290: L1069-L1077, 2006.
31. Hagendoorn J, Padera TP, Fukumura D, Jain RK. Molecular regulation of microlymphatic formation and function: role of nitric oxide. Trends Cardiovasc Med 15: 169-173, 2005.
32. Hagendoorn J, Padera TP, Kashiwagi S, Isaka N, Noda F, Lin MI, Huang PL, Sessa WC, Fukumura D, Jain RK. Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 95: 204-209, 2004.
33. Hoffman JI, Rudolph AM. The natural history of ventricular septal defects in infancy. Am J Cardiol 16: 634-653, 1965.
34. Hosking B, Makinen T. Lymphatic vasculature: a molecular perspective. Bioessays 29: 1192-1202, 2007.
35. Ikomi F, Kawai Y, Nakayama J, Ogiwara N, Sasaki K, Mizuno R, Ohhashi T. Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice. Microcirculation 15: 591-603, 2008.
36. Johnson EG, Wisner ER, Kyles A, Koehler C, Marks SL. Computed tomographic lymphography of the thoracic duct by mesenteric lymph node injection. Vet Surg 38: 361-367, 2009.
37. Kajiya K, Huggenberger R, Drinnenberg I, Ma B, Detmar M. Nitric oxide mediates lymphatic vessel activation via soluble guanylate cyclase _1_1-impact on inflammation. FASEB J 22: 530-537, 2008.
38. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80, 2004.
39. Karpanen T, Makinen T. Regulation of lymphangiogenesis-from cell fate determination to vessel remodeling. Exp Cell Res 312: 575-583, 2006.
40. Lahdenranta J, Hagendoorn J, Padera TP, Hoshida T, Nelson G, Kashiwagi S, Jain RK, Fukumura D. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res 69: 2801-2808, 2009.
41. Lakshminrusimha S, Wiseman D, Black SM, Russell JA, Gugino SF, Oishi P, Steinhorn RH, Fineman JR. The role of nitric oxide synthasederived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 293: H1491-H1497, 2007.
42. Landolt CC, Matthay MA, Albertine KH, Roos PJ, Wiener-Kronish JP, Staub NC. Overperfusion, hypoxia, and increased pressure cause only hydrostatic pulmonary edema in anesthetized sheep. Circ Res 52: 335-341, 1983.
43. Loscalzo ML, Van PL, Ho VB, Bakalov VK, Rosing DR, Malone CA, Dietz HC, Bondy CA. Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome. Pediatrics 115: 732-735, 2005.
44. Matthay MA, Landolt CC, Staub NC. Differential liquid and protein clearance from the alveoli of anesthetized sheep. J Appl Physiol 53: 96-104, 1982.
45. Maybauer DM, Talke PO, Westphal M, Maybauer MO, Traber LD, Enkhbaatar P, Morita N, Traber DL. Positive end-expiratory pressure ventilation increases extravascular lung water due to a decrease in lung lymph flow. Anaesth Intensive Care 34: 329-333, 2006.
46. McMullan DM, Bekker JM, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR. Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am J Physiol Heart Circ Physiol 280: H777-H785, 2001.
47. McMullan DM, Bekker JM, Parry AJ, Johengen MJ, Kon A, Heidersbach RS, Black SM, Fineman JR. Alterations in endogenous nitric oxide production after cardiopulmonary bypass in lambs with normal and increased pulmonary blood flow. Circulation 102: III172-III178, 2000.
48. Meadows J, Gauvreau K, Jenkins K. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease. Congenit Heart Dis 3: 269-276, 2008.
49. Noonan JA, Walters LR, Reeves JT. Congenital pulmonary lymphangiectasis. Am J Dis Child 120: 314-319, 1970.
50. Ohkuda K, Nakahara K, Weidner WJ, Binder A, Staub NC. Lung fluid exchange after uneven pulmonary artery obstruction in sheep. Circ Res 43: 152-161, 1978.
51. Oishi P, Azakie A, Harmon C, Fitzgerald RK, Grobe A, Xu J, Hendricks-Munoz K, Black SM, Fineman JR. Nitric oxide-endothelin-1 interactions after surgically induced acute increases in pulmonary blood flow in intact lambs. Am J Physiol Heart Circ Physiol 290: H1922-H1932, 2006.
52. Oishi PE, Wiseman DA, Sharma S, Kumar S, Hou Y, Datar SA, Azakie A, Johengen MJ, Harmon C, Fratz S, Fineman JR, Black SM. Progressive dysfunction of nitric oxide synthase in a lamb model of chronically increased pulmonary blood flow: a role for oxidative stress. Am J Physiol Lung Cell Mol Physiol 295: L756-L766, 2008.
53. Oliver G, Srinivasan RS. Lymphatic vasculature development: current concepts. Ann NY Acad Sci 1131: 75-81, 2008.
54. Ovadia B, Reinhartz O, Fitzgerald R, Bekker JM, Johengen MJ, Azakie A, Thelitz S, Black SM, Fineman JR. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 284: H480-H490, 2003.
55. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, Fineman JR. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613, 1995.
56. Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol 34: 554-560, 1999.
57. Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Yla-Herttuala S, Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 196: 719-730, 2002.
58. Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol 193: 607-618, 2011.
59. Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS. Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol 7: 29-45, 2009.
60. Staub NC, Bland RD, Brigham KL, Demling R, Erdmann AJ, 3rd, Woolverton WC. Preparation of chronic lung lymph fistulas in sheep. J Surg Res 19: 315-320, 1975.
61. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16: 1985-1987, 2002.
62. Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, An A, Dadras SS, Rockson N, Joshi S, Wagner R, Rockson SG. Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med 3: e254, 2006.
63. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476, 2010.
64. Tammela T, Saaristo A, Holopainen T, Lyytikka J, Kotronen A, Pitkonen M, Abo-Ramadan U, Yla-Herttuala S, Petrova TV, Alitalo K. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 13: 1458-1466, 2007.
65. Tsunemoto H, Ikomi F, Ohhashi T. Flow-mediated release of nitric oxide from lymphatic endothelial cells of pressurized canine thoracic duct. Jpn J Physiol 53: 157-163, 2003.
66. Vasquez JC, Rabah R, Delius RE, Walters HL. Hypoplastic left heart syndrome with intact atrial septum associated with deletion of the short arm of chromosome 18. Cardiovasc Pathol 12: 102-104, 2003.
67. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, Black SM. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89: 357-364, 2001.
68. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminiski PM, Wolin MS, Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91: 2982-2988, 1995.